Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry

BACKGROUND: Treatment of systemic onset juvenile idiopathic arthritis JIA (sJIA), although dramatically improved, remains a challenge. Experience from clinical practice will be presented using data from the German Biologics register (BiKeR) for evaluation of efficacy and safety of treatment with eta...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Arthritis Res Ther
Egile Nagusiak: Horneff, Gerd, Schulz, Anna Carina, Klotsche, Jens, Hospach, Anton, Minden, Kirsten, Foeldvari, Ivan, Trauzeddel, Ralf, Ganser, Gerd, Weller-Heinemann, Frank, Haas, Johannes Perter
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2017
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700562/
https://ncbi.nlm.nih.gov/pubmed/29166924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-017-1462-2
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak